<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Color Imaging, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.01 PER SHARE
--------------------------------------------------------------------------------
(Title of Class of Securities)
196245104
--------------------------------------------------------------------------------
(CUSIP Number)
MICHAEL BRENNAN, c/o COLOR IMAGING SOLUTIONS, INC.,
--------------------------------------------------------------------------------
4350 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 100 NORCROSS, GEORGIA 30071
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
December 29, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and
is filing this schedule because of Sections 240.13d-l(e), 240.13d-l(f)
or 240.13d-l(g), check the following box [ ].
NOTE: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Section
240-13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP No......196245104
<PAGE> 2
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Dr. Sueling Wang
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ...............................................................
(b) ...............................................................
--------------------------------------------------------------------------------
3. SEC Use Only.........................................................
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions) ................................00
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)................................................[ ]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization: ...........................U.S.
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power...................................448,500
Shares Bene- ----------------------------------------------------------------
ficially
Owned by Each 8. Shared Voting Power ...............................156,000
Reporting ----------------------------------------------------------------
Person With
9. Sole Dispositive Power .............................448,500
----------------------------------------------------------------
10. Shared Dispositive Power ...............................0
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting
Person .......................................................448,500
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) ........... 6.40%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)....................... IN
--------------------------------------------------------------------------------
2
<PAGE> 3
INSTRUCTIONS FOR COVER PAGE
(1) Names and I.R.S. Identification Numbers of Reporting Persons
-- Furnish the full legal name of each person for whom the
report is filed - i.e., each person required to sign the
schedule itself - including each member of a group. Do not
include the name of a person required to be identified in the
report but who is not a reporting person. Reporting persons
that are entities are also requested to furnish their I.R.S.
identification numbers, although disclosure of such numbers is
voluntary, not mandatory (see "SPECIAL INSTRUCTIONS FOR
COMPLYING WITH SCHEDULE 13D" below).
(2) If any of the shares beneficially owned by a reporting person
are held as a member of a group and the membership is
expressly affirmed, please check row 2(a). If the reporting
person disclaims membership in a group or describes a
relationship with other persons but does not affirm the
existence of a group, please check row 2(b) [unless it is a
joint filing pursuant to Rule 13d-l(k)(1) in which case it may
not be necessary to check row 2(b)].
(3) The 3rd row is for SEC internal use; please leave blank.
ITEM 1. SECURITY AND ISSUER
The title of the class of equity securities to which this Statement on
Schedule 13D relates is the common stock, par value $.01 per share (the "Common
Stock"), of Color Imaging, Inc., a Delaware corporation (the "Issuer"). The
address of the principal executive offices of the Issuer is 4350 Peachtree
Industrial Blvd., Suite 100, Norcross, Georgia 30071.
ITEM 2. IDENTITY AND BACKGROUND
This Statement on Schedule 13D is being filed by Dr. Sueling Wang,
President and Director of the Issuer. The business address of Dr. Sueling Wang
is Color Imaging, Inc., 4350 Peachtree Industrial Blvd., Suite 100, Norcross,
Georgia 30071.
During the last five years, Dr. Wang has not been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors), nor
has Dr. Wang been a party to a civil proceeding of a judicial or administrative
body of competent jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, Federal or state securities laws
or finding any violation with respect to such laws. Dr. Wang is a U.S. citizen.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
3
<PAGE> 4
Dr. Wang acquired 100,000 shares of common stock and warrants to
purchase 100,000 shares of common stock from the Issuer in a private transaction
on December 29, 2000 in exchange for $200,000. Dr. Wang used personal funds to
acquire the above securities from the Issuer.
ITEM 4. PURPOSE OF TRANSACTION.
See Item 3 above. Dr. Wang acquired such securities in order to
increase his equity ownership in the Issuer and for personal use.
Currently, Dr. Wang has no plans or proposals of the type referred to
in paragraphs (a) through (j).
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) Sueling Wang owns 448,500 shares of common stock of the Issuer
representing approximately 6.40% of the issued and outstanding shares. 100,000
of the 448,500 number reflect shares of common stock underlying presently
exercisable options.
(b) Sueling Wang has the sole power to vote and dispose of
448,500 shares of common stock of the Issuer. Dr. Wang shares voting power with
respect to 156,000 shares of common stock, representing: (a) 96,000 shares of
common stock beneficially held by Dr. Wang's wife, Yik-Li Sih, and (b) 60,000
shares of common stock beneficially held by his three children, with his wife
and three children. Dr. Wang disclaims beneficial ownership of such 156,000
shares.
The residential address of Yik-li Sih is 1105 Ascott Valley Drive,
Duluth, Georgia 30096. Ms. Sih's principal occupation is real estate investor.
During the last five years, Ms. Sih has not been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors), nor
has Ms. Sih been a party to a civil proceeding of a judicial or administrative
body of competent jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, Federal or state securities laws
or finding any violation with respect to such laws. Ms. Sih is a U.S. citizen.
The residential address for Daniel Wang, Michael Wang, Elizabeth Wang,
and Justin Wang is 1105 Ascott Valley Drive, Duluth, Georgia 30096. Daniel Wang
is a college student and Michael Wang, Elizabeth Wang and Justin Wang are
minors.
During the last five years, Daniel Wang, Michael Wang, Elizabeth Wang,
and Justin Wang have not been convicted in a criminal proceeding (excluding
traffic violations or similar misdemeanors), nor have Daniel Wang, Michael Wang,
Elizabeth Wang, and Justin Wang been a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result of such
proceeding was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to, Federal
or state securities laws or finding any violation with respect to such laws.
Daniel Wang, Michael Wang, Elizabeth Wang, and Justin Wang are U.S. citizens.
4
<PAGE> 5
(c) See Item 3 above.
(d) Not applicable.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER.
Not applicable.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Statement on Schedule 13D is
true, complete and correct.
Date: January 8, 2001
/s/ Dr. Sueling Wang
--------------------
Dr. Sueling Wang
5
